Iradimed (IRMD) News Today $56.24 -0.90 (-1.58%) Closing price 04:00 PM EasternExtended Trading$56.26 +0.02 (+0.04%) As of 04:05 PM Eastern Extended trading is trading that happens on electronic markets outside of regular trading hours. This is a fair market value extended hours price provided by Polygon.io. Learn more. Add Compare Share Share Headlines Stock AnalysisAnalyst ForecastsChartCompetitorsDividendEarningsFinancialsHeadlinesInsider TradesOptions ChainOwnershipSEC FilingsShort InterestSustainabilityTrends All Sources Trusted Sources MarketBeat Benzinga Bloomberg GuruFocus MarketWatch Motley Fool NASDAQ PR Newswire Reuters Seeking Alpha TalkMarkets The Street TipRanks The Wall Street Journal Wall Street Zen Yahoo Finance Source Sentiment refers to the positivity or negativity of each headline according to our language processing algorithm. Sentiment All Sentiments Very Positive Positive Neutral Negative Very Negative Most Recent February 2025 January 2025 December 2024 November 2024 October 2024 September 2024 August 2024 July 2024 June 2024 May 2024 April 2024 March 2024 February 2024 January 2024 December 2023 November 2023 October 2023 September 2023 August 2023 July 2023 June 2023 May 2023 April 2023 March 2023 February 2023 January 2023 December 2022 November 2022 October 2022 September 2022 August 2022 July 2022 June 2022 May 2022 April 2022 March 2022 Time Period Iradimed (NASDAQ:IRMD) Raised to Strong-Buy at StockNews.comStockNews.com raised shares of Iradimed from a "buy" rating to a "strong-buy" rating in a report on Friday.February 21 at 2:22 AM | marketbeat.comIRadimed Corporation (NASDAQ:IRMD) Q4 2024 Earnings Call TranscriptFebruary 17, 2025 | msn.comEarnings Update: Here's Why Analysts Just Lifted Their IRADIMED CORPORATION (NASDAQ:IRMD) Price Target To US$71.00February 16, 2025 | finance.yahoo.comIradimed (NASDAQ:IRMD) Lowered to "Buy" Rating by StockNews.comFebruary 16, 2025 | americanbankingnews.comIradimed Corporation (NASDAQ:IRMD) Announces Dividend Increase - $0.17 Per ShareIradimed Corporation (NASDAQ:IRMD) declared a quarterly dividend on Friday, February 14th. Stockholders of record on Monday, February 24th will be given a dividend of 0.17 per share by the medical equipment provider on Wednesday, March 5th. This represents a $0.68 dividend on an annualized basis and a dividend yield of 1.23%. The ex-dividend date is Monday, February 24th. This is a boost from Iradimed's previous quarterly dividend of $0.15.February 15, 2025 | marketbeat.comIradimed (NASDAQ:IRMD) Receives "Buy" Rating from Roth MkmRoth Mkm reissued a "buy" rating and issued a $72.00 price objective (up previously from $60.00) on shares of Iradimed in a research report on Friday.February 15, 2025 | marketbeat.comiRadimed price target raised to $72 from $60 at Roth MKMFebruary 14, 2025 | markets.businessinsider.comIRadimed projects $78M-$82M revenue for FY2025 amid strong pump demand and FDA clearance timelinesFebruary 14, 2025 | seekingalpha.comiRadimed reports Q4 EPS 44c vs 39c last yearFebruary 14, 2025 | markets.businessinsider.comEarnings call transcript: Iradimed Co Q4 2024 beats EPS forecasts, stock dropsFebruary 13, 2025 | msn.comIradimed (NASDAQ:IRMD) Releases FY 2025 Earnings GuidanceIradimed (NASDAQ:IRMD) updated its FY 2025 earnings guidance. The company provided EPS guidance of 1.710-1.810 for the period, compared to the consensus estimate of 1.750. The company also issued revenue guidance of $78.0 millionillion-$82.0 millionillion, compared to the consensus estimate of $80.7 millionillion.February 13, 2025 | marketbeat.comIradimed (NASDAQ:IRMD) Updates Q1 2025 Earnings GuidanceIradimed (NASDAQ:IRMD) updated its first quarter 2025 earnings guidance. The company provided EPS guidance of 0.390-0.430 for the period, compared to the consensus estimate of 0.410. The company also issued revenue guidance of $19.2 millionillion-$19.4 millionillion, compared to the consensus estimate of $19.1 millionillion.February 13, 2025 | marketbeat.comIradimed (NASDAQ:IRMD) Announces Quarterly Earnings ResultsIradimed (NASDAQ:IRMD - Get Free Report) issued its quarterly earnings data on Thursday. The medical equipment provider reported $0.40 EPS for the quarter, missing the consensus estimate of $0.45 by ($0.05). Iradimed had a return on equity of 23.99% and a net margin of 26.12%.February 13, 2025 | marketbeat.comIradimed (NASDAQ:IRMD) Shares Gap Down on Disappointing EarningsIradimed (NASDAQ:IRMD) Shares Gap Down Following Weak EarningsFebruary 13, 2025 | marketbeat.comStockNews.com Downgrades Iradimed (NASDAQ:IRMD) to BuyStockNews.com lowered shares of Iradimed from a "strong-buy" rating to a "buy" rating in a research note on Thursday.February 13, 2025 | marketbeat.comIradimed (IRMD) Projected to Post Quarterly Earnings on ThursdayIradimed (NASDAQ:IRMD) will be releasing earnings before the market opens on Thursday, February 13, Financial Modeling Prep reports. (Register for Conference Call at http://mmm.wallstreethorizon.com/u.asp?u=517354)February 6, 2025 | marketbeat.comIradimed (NASDAQ:IRMD) Downgraded by StockNews.com to BuyStockNews.com lowered Iradimed from a "strong-buy" rating to a "buy" rating in a research note on Wednesday.February 5, 2025 | marketbeat.comIradimed (NASDAQ:IRMD) Reaches New 52-Week High - Still a Buy?Iradimed (NASDAQ:IRMD) Reaches New 12-Month High - What's Next?February 4, 2025 | marketbeat.comIradimed Corporation (NASDAQ:IRMD) Short Interest Up 18.2% in JanuaryIradimed Corporation (NASDAQ:IRMD - Get Free Report) saw a significant growth in short interest in January. As of January 15th, there was short interest totalling 124,100 shares, a growth of 18.2% from the December 31st total of 105,000 shares. Based on an average daily volume of 39,400 shares, the short-interest ratio is presently 3.1 days. Approximately 1.6% of the company's shares are sold short.February 2, 2025 | marketbeat.comCopeland Capital Management LLC Increases Stock Holdings in Iradimed Corporation (NASDAQ:IRMD)Copeland Capital Management LLC boosted its position in shares of Iradimed Corporation (NASDAQ:IRMD - Free Report) by 12.6% in the fourth quarter, according to the company in its most recent filing with the SEC. The firm owned 475,563 shares of the medical equipment provider's stock after acquiringFebruary 2, 2025 | marketbeat.comIRADIMED CORPORATION to Hold Fourth Quarter of 2024, Full Year of 2024 Financial Results Conference Call on February 13, 2025January 30, 2025 | globenewswire.comIradimed (NASDAQ:IRMD) Upgraded by StockNews.com to "Strong-Buy" RatingStockNews.com raised Iradimed from a "buy" rating to a "strong-buy" rating in a research report on Tuesday.January 28, 2025 | marketbeat.comIRADIMED's (NASDAQ:IRMD) investors will be pleased with their solid 156% return over the last five yearsJanuary 28, 2025 | finance.yahoo.comIRMD Stock Soars to All-Time High, Reaching $61 Amidst 40.55% Yearly SurgeJanuary 28, 2025 | msn.comIradimed (NASDAQ:IRMD) Hits New 52-Week High - What's Next?Iradimed (NASDAQ:IRMD) Reaches New 12-Month High - Still a Buy?January 28, 2025 | marketbeat.comJPMorgan Chase & Co. Buys 12,051 Shares of Iradimed Corporation (NASDAQ:IRMD)JPMorgan Chase & Co. boosted its stake in Iradimed Corporation (NASDAQ:IRMD - Free Report) by 70.2% during the 3rd quarter, according to its most recent 13F filing with the Securities and Exchange Commission. The institutional investor owned 29,226 shares of the medical equipment provider's stockJanuary 24, 2025 | marketbeat.comIradimed (NASDAQ:IRMD) Hits New 1-Year High - Still a Buy?Iradimed (NASDAQ:IRMD) Reaches New 1-Year High - Time to Buy?January 21, 2025 | marketbeat.comIradimed Corporation (NASDAQ:IRMD) Short Interest UpdateIradimed Corporation (NASDAQ:IRMD - Get Free Report) was the recipient of a large increase in short interest in the month of December. As of December 31st, there was short interest totalling 124,100 shares, an increase of 18.2% from the December 15th total of 105,000 shares. Approximately 1.6% of the shares of the company are sold short. Based on an average daily volume of 39,400 shares, the short-interest ratio is presently 3.1 days.January 19, 2025 | marketbeat.comIRMD stock soars to all-time high of $59.3 amid robust growthJanuary 17, 2025 | msn.comIradimed (NASDAQ:IRMD) Sets New 12-Month High - What's Next?Iradimed (NASDAQ:IRMD) Hits New 52-Week High - What's Next?January 15, 2025 | marketbeat.comBarclays PLC Boosts Stake in Iradimed Corporation (NASDAQ:IRMD)Barclays PLC increased its stake in Iradimed Corporation (NASDAQ:IRMD - Free Report) by 113.9% during the 3rd quarter, according to the company in its most recent disclosure with the Securities and Exchange Commission. The fund owned 23,774 shares of the medical equipment provider's stock after purJanuary 14, 2025 | marketbeat.comIradimed (IRMD) Gets a Buy from Lake StreetJanuary 10, 2025 | markets.businessinsider.comIradimed Reports Growth In Q4, FY Preliminary RevenuesJanuary 10, 2025 | markets.businessinsider.comiRadimed reports preliminary Q4 revenue $19.2M-$19.4MJanuary 10, 2025 | markets.businessinsider.comIRADIMED CORPORATION Reports Preliminary Unaudited Record Fourth Quarter and Full-Year 2024 RevenuesJanuary 10, 2025 | globenewswire.comDiscovering Undiscovered Gems with Strong Potential This December 2024January 1, 2025 | finance.yahoo.comIradimed Corporation (NASDAQ:IRMD) Sees Significant Growth in Short InterestIradimed Corporation (NASDAQ:IRMD - Get Free Report) saw a large increase in short interest in December. As of December 15th, there was short interest totalling 105,000 shares, an increase of 22.0% from the November 30th total of 86,100 shares. Currently, 1.3% of the company's stock are short sold. Based on an average trading volume of 39,100 shares, the days-to-cover ratio is presently 2.7 days.December 31, 2024 | marketbeat.comBarclays PLC Has $1.20 Million Stake in Iradimed Corporation (NASDAQ:IRMD)Barclays PLC lifted its stake in shares of Iradimed Corporation (NASDAQ:IRMD - Free Report) by 113.9% during the 3rd quarter, according to its most recent 13F filing with the Securities and Exchange Commission. The fund owned 23,774 shares of the medical equipment provider's stock after purchasingDecember 30, 2024 | marketbeat.comIRADIMED CORPORATION to Present at the 43rd Annual J.P. Morgan Healthcare ConferenceDecember 19, 2024 | globenewswire.comCharles Schwab Investment Management Inc. Has $3.35 Million Stake in Iradimed Corporation (NASDAQ:IRMD)Charles Schwab Investment Management Inc. lifted its holdings in Iradimed Corporation (NASDAQ:IRMD - Free Report) by 189.7% in the 3rd quarter, according to the company in its most recent filing with the Securities and Exchange Commission. The institutional investor owned 66,632 shares of the mediDecember 15, 2024 | marketbeat.comShould You Investigate IRADIMED CORPORATION (NASDAQ:IRMD) At US$54.43?December 13, 2024 | uk.finance.yahoo.comIradimed Corporation (NASDAQ:IRMD) Shares Sold by HighTower Advisors LLCHighTower Advisors LLC cut its stake in shares of Iradimed Corporation (NASDAQ:IRMD - Free Report) by 20.0% during the third quarter, according to its most recent Form 13F filing with the Securities and Exchange Commission (SEC). The fund owned 82,356 shares of the medical equipment provider's stocDecember 12, 2024 | marketbeat.comIRADIMED CORPORATION on Forbes’ List of America’s Most Successful Small-Cap Companies for 2025December 10, 2024 | markets.businessinsider.comIRADIMED CORPORATION on Forbes' List of America's Most Successful Small-Cap Companies for 2025December 10, 2024 | globenewswire.comiRadimed (NASDAQ:IRMD) Stock Quotes, Forecast and News SummaryDecember 4, 2024 | benzinga.comJohn Glenn Sells 2,500 Shares of Iradimed Corporation (NASDAQ:IRMD) StockDecember 3, 2024 | insidertrades.comIradimed Corporation (NASDAQ:IRMD) Shares Sold by Isthmus Partners LLCIsthmus Partners LLC reduced its position in shares of Iradimed Corporation (NASDAQ:IRMD - Free Report) by 20.4% during the 3rd quarter, according to its most recent filing with the Securities and Exchange Commission (SEC). The fund owned 57,818 shares of the medical equipment provider's stock afteNovember 29, 2024 | marketbeat.comIs There An Opportunity With IRADIMED CORPORATION's (NASDAQ:IRMD) 47% Undervaluation?November 26, 2024 | finance.yahoo.comEagle Asset Management Inc. Takes Position in Iradimed Corporation (NASDAQ:IRMD)Eagle Asset Management Inc. acquired a new position in shares of Iradimed Corporation (NASDAQ:IRMD - Free Report) in the 3rd quarter, according to its most recent 13F filing with the Securities and Exchange Commission. The institutional investor acquired 24,632 shares of the medical equipment provNovember 26, 2024 | marketbeat.comIRADIMED CORPORATION (NASDAQ:IRMD) Passed Our Checks, And It's About To Pay A US$0.15 DividendNovember 10, 2024 | finance.yahoo.com Get Iradimed News Delivered to You Automatically Sign up to receive the latest news and ratings for IRMD and its competitors with MarketBeat's FREE daily newsletter. Email Address IRMD Media Mentions By Week IRMD Media Sentiment Learn about the media sentiment score. Each headline receives a score ranging from 2 (good news) to -2 (bad news). Our company news sentiment scores track the average news sentiment of articles about each company over the most recent 7 days in order to identify companies that are receiving positive press. IRMD News Sentiment▼0.470.60▲Average Medical News Sentiment IRMD News Coverage Learn about the media coverage comparison. We track news headlines from hundreds of news outlets and tag them by company. This chart compares the number of articles about this company in the last seven days compared with the average number of articles about this company on a typical week. IRMD Articles This Week▼72▲IRMD Articles Average Week Get Iradimed News Delivered to You Automatically Sign up to receive the latest news and ratings for IRMD and its competitors with MarketBeat's FREE daily newsletter. Email Address Related Companies and Tools Related Companies WRBY News Today LIVN News Today ENOV News Today NVCR News Today TMDX News Today LMAT News Today TNDM News Today SLNO News Today CNMD News Today CDRE News Today Headlines Tools Trending Media MentionsHigh Media Sentiment StocksLive News FeedMarketBeat OriginalsStock Ideas This page (NASDAQ:IRMD) was last updated on 2/21/2025 by MarketBeat.com Staff From Our PartnersCollect $7k per month from Tesla’s SECRET dividendTesla doesn't pay a traditional dividend.... But I just discovered a secret backdoor to collect a secret 69...Investors Alley | SponsoredElon “obliterates” Bill Gates?All 10 of the world's biggest money managers follow my work, and the Pentagon, the FBI and Harvard professors ...Altimetry | SponsoredNVDA Crash UpdateAn overseas AI rival sent shockwaves through the U.S. tech market last week... Leaving millions of investor...Chaikin Analytics | SponsoredHas Trump finally met his match?Dylan Jovine predicted the 2008 crash over a year before it happened. Folks who listened to him had the chance...Behind the Markets | Sponsored$2 Trillion Disappears Because of Fed's Secretive New Move$2 trillion has disappeared from the US government's books. The reason why is a new, secretive move being c...Stansberry Research | Sponsored Is Starlink Set For The Largest IPO In History?He turned PayPal from a tiny, off-the-radar startup… to a massive $64 billion giant. Then, he did it again ...Paradigm Press | Sponsored My 2025 AI BlueprintI first recommended Bitcoin at $300 in 2013 … before it went up 33,645%. Now, I am revealing my 2025 AI Blu...Weiss Ratings | SponsoredBetter than Bitcoin – and potentially more profitableThe world is obsessed with Bitcoin again... And for a good reason: It just soared beyond $100,000. Bitcoin ...Brownstone Research | Sponsored Adding Choose a watchlist: Watchlist Adding You have already added five stocks to your watchlist. Upgrade to MarketBeat All Access to add more stocks to your watchlist. Adding Iradimed Corporation Please log in to your account or sign up in order to add this asset to your watchlist. Share Iradimed With A Colleague Link copied to clipboard. Get 30 Days of MarketBeat All Access for Free Sign up for MarketBeat All Access to gain access to MarketBeat's full suite of research tools. Start Your 30-Day Trial MarketBeat All Access Features Best-in-Class Portfolio Monitoring Get personalized stock ideas. Compare portfolio to indices. Check stock news, ratings, SEC filings, and more. Stock Ideas and Recommendations See daily stock ideas from top analysts. Receive short-term trading ideas from MarketBeat. Identify trending stocks on social media. Advanced Stock Screeners and Research Tools Use our seven stock screeners to find suitable stocks. Stay informed with MarketBeat's real-time news. Export data to Excel for personal analysis. Sign in to your free account to enjoy these benefits In-depth profiles and analysis for 20,000 public companies. Real-time analyst ratings, insider transactions, earnings data, and more. Our daily ratings and market update email newsletter. Sign in to your free account to enjoy all that MarketBeat has to offer. Sign In Create Account Your Email Address: Email Address Required Your Password: Password Required Log In or Sign in with Facebook Sign in with Google Forgot your password? Your Email Address: Please enter your email address. Please enter a valid email address Choose a Password: Please enter your password. Your password must be at least 8 characters long and contain at least 1 number, 1 letter, and 1 special character. Create My Account (Free) or Sign in with Facebook Sign in with Google By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.
